Joseph A. Tyndall, Director at Axogen, Inc. (AXGN), sold 3,500 shares at $49.70 ($174K) on 2026-09-02, disclosed to the SEC on 2026-09-04.
Scheduled sale ($174k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AXGN | SELL | 2025-05-23 | $29K | — | Filing → |
| AXGN | SELL | 2025-05-23 | $305K | — | Filing → |